Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Geranium robertianum extract is an aqueous preparation derived from the leaves of the *Geranium robertianum* L. plant, a member of the Geraniaceae family commonly known as Herb-Robert or Red Robin. Traditionally used in folk medicine for its antioxidant and anti-inflammatory properties to treat conditions such as ulcers, diarrhea, and wounds, the extract is currently being investigated for its neuroprotective potential in neurodegenerative disorders. Research conducted by Erzurum Technical University suggests that the extract may offer therapeutic benefits for Parkinson's disease by ameliorating 1-methyl-4-phenylpyridinium (MPP+)-induced neurotoxicity. Its mechanism of action involves the regulation of oxidative stress machinery (increasing total antioxidant status and decreasing total oxidative status), the inhibition of apoptosis, and the modulation of acetylcholinesterase (AChE) activity. The extract contains various bioactive phytochemicals, including linalool, geraniol, and alpha-caryophyllene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on geranium robertianum extract.